STOCK FUTURES INCH UP AS HIGH-FLYING Q2 NEARS CLOSE

S&P 500 is up around 4.5% this quarter, while the Nasdaq has surged about 8%

MYGN Jun 2024 26.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.6000

0.0000

(0.00%)

As of 01:47PM EDT. Market open.

Loading interactive chart...

Simply Wall St.
An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 30% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Myriad Genetics fair value estimate is US$34.23 Current share...
Zacks
Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Myriad Genetics (MYGN) collaborates with GSK to improve access to HRD diagnostic testing for HGSOC patients.
Zacks
Myriad Genetics (MYGN) Banks on Innovation Amid Macro Woes
Myriad Genetics (MYGN) continues to enhance its customer targeting, digital marketing and overall operating model to drive commercial leverage in 2024 and beyond.